Table 1.
Characteristics of the Study Population, by Gravidity Statusa
| Characteristic | Primigravidae (n = 172, 18.45%) | Secundigravidae (n = 187, 20.06%) | Multigravidae (n = 573, 61.48%) | P Value |
|---|---|---|---|---|
| Age, years | 20.10 (19.74; 20.46) | 22.29 (21.80; 22.79) | 28.77 (28.38; 29.16) | <.001 |
| BMI before pregnancy (kg/m2) | 20.41 (19.98; 20.84) | 20.66 (20.18; 21.13) | 21.35 (21.02; 21.68) | .01 |
| IPTp regime | ||||
| SP | 56 (32.56%) | 64 (34.22%) | 198 (34.55%) | .89 |
| MQ | 116 (67.44%) | 123 (65.78%) | 375 (65.45%) | .89 |
| Gestational age at ANV1 (weeks) | 22.06 (21.52; 22.61) | 22.11 (21.50; 22.71) | 22.20 (21.87; 22.52) | .77 |
| Gestational age at ANV2 | 28.41 (27.82; 29.01) | 28.88 (28.33; 29.42) | 28.97 (28.66; 29.28) | .21 |
| Gestational age at delivery | 38.37 (37.85; 38.89) | 37.86 (37.38; 38.34) | 38.20 (37.92; 38.48) | .42 |
| Number of positive smears during pregnancy | 0.84 (0.63; 1.05) | 0.86 (0.63; 1.09) | 0.32 (0.24; 0.40) | .42 |
| Placental malaria | 20 (15.27%) | 20 (13.42%) | 28 (5.97%) | .001 |
| Low birth weight | 31 (18.02%) | 20 (10.70%) | 43 (7.50%) | <.001 |
Abbreviations: ANV, antenatal visit; BMI, body mass index; IPTp, intermittent preventive treatment; MQ, mefloquine; SP, sulphadoxine-pyrimethamine.
a For continuous variables, the mean is provided followed by the 95% confidence interval in brackets. For categorical variables, n is presented followed by the % in brackets.